Resources

Long COVID‑19 Clinics

Product: — Evidence Synthesis Network

Long Covid Regulation & Policy Workplace Regulations

esnetwork.ca Last Updated: April 27, 2021

Chloroquine or Hydroxychloroquine to Prevent or Treat COVID-19

Product: — Canadian Agency for Drugs and Technologies in Health

Drug Interventions Treatments

covid.cadth.ca Last Updated: April 26, 2021

Also available in Français

Clinical Practice Guidelines Webinar: Tocilizumab

Product: — Science Table

Drug Interventions Healthcare Workers Models Treatments

covid19-sciencetable.ca Last Updated: April 26, 2021

Ongoing Trials for Drugs in the Prevention and Treatment of COVID-19

Product: — Canadian Agency for Drugs and Technologies in Health

Drug Interventions Treatments

covid.cadth.ca Last Updated: April 22, 2021

Also available in Français

Strategies to Manage Tocilizumab Supply During the COVID‑19 Pandemic

Product: — Science Table

Drug Interventions Future Planning Treatments

covid19-sciencetable.ca Last Updated: April 19, 2021

Understanding Long COVID-19

Product: — Evidence Synthesis Network

Long Covid Signs & Symptoms

esnetwork.ca Last Updated: April 7, 2021

Clinical Practice Guideline Summary: Recommended Drugs and Biologics in Adult Patients with COVID-19

Product: — Science Table

Drug Interventions Treatments

covid19-sciencetable.ca Last Updated: April 6, 2021

Vaccine-Induced Prothrombotic Immune Thrombocytopenia (VIPIT) following AstraZeneca COVID‑19 Vaccination: Interim Guidance for Healthcare Professionals in Emergency Department and Inpatient Settings

Product: — Science Table

Clinicians Healthcare Workers Regulation & Policy Vaccine Vaccines & Immunity

covid19-sciencetable.ca Last Updated: April 2, 2021

Vaccine-Induced Prothrombotic Immune Thrombocytopenia (VIPIT) following AstraZeneca COVID‑19 Vaccination: Interim Guidance for Healthcare Professionals in the Outpatient Setting

Product: — Science Table

Healthcare Workers Immune System Vaccine Vaccines & Immunity

covid19-sciencetable.ca Last Updated: April 2, 2021

Tocilizumab and Sarilumab: Evidence Review and Appraisal

Product: — Canadian Agency for Drugs and Technologies in Health

Drug Interventions Treatments

covid.cadth.ca Last Updated: March 25, 2021

Also available in Français